Search

everythinglearnresearchcommunity

for

Search:↓

Many COVID-19 survivors experience long-lasting symptoms, including hair loss and psychological issues.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.

Post-COVID-19 hair loss is likely due to stress and inflammation.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

Post-COVID-19 hair loss is different from androgenetic alopecia and can be identified by lower copper and higher selenium levels.

Post-COVID-19 hair loss is not linked to vitamin D or quality of life but is linked to hair graying.

Homoeopathy has helped treat hair loss after Covid-19, considering the patient's overall condition.

Post-COVID-19 patients are at risk for hair loss.

A woman experienced sudden hair graying and loss after a COVID-19 vaccine, which improved with treatment.

A person with a new mutation in the SCN1A gene developed brain inflammation after COVID-19.

Some COVID-19 pneumonia patients in Veracruz, Mexico had rare skin issues like temporary hair loss linked to disease severity.

Some COVID-19 patients in Saudi Arabia had skin symptoms, with rashes being the most common.

No significant link between male pattern baldness and severe Covid-19, but some shared biological pathways exist.

COVID-toes show a unique immune response over time, different from vaccine-related chilblains.

Minoxidil can improve hair growth in some patients with woolly hair due to LIPH variants, with varying responses and mild side effects.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.

The Covishield COVID-19 vaccine caused skin-related side effects in 1.23% of the people vaccinated in the study from India.

Long-lasting COVID-19 symptoms like fatigue and breathing difficulties can persist for over 60 days, requiring ongoing care.

Male hormones may make COVID-19 worse, while substances that block these hormones could lessen symptoms.

Most skin reactions to COVID-19 vaccines in India were mild and not a reason to avoid vaccination.

The AndroCoV Clinical Scoring is an accurate, easy, and free way to diagnose COVID-19 without a lab test.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Convalescent Plasma Therapy may help treat COVID-19 Long-Hauler symptoms.